Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
GLP-1 medications are designed to act like this natural hormone, but often with a longer-lasting effect
These prescription medications trigger a hormonal response to reduce annoying feelings of hunger and help silence relentless food noise
Results published in The Lancet showed significant improvements in both weight and glycemic control (Rosenstock et al., 2023): Participants lost up to 16.9% of body weight (lower than the non-diabetic cohort, consistent with other medication studies) HbA1c reductions of up to 2.02 percentage points , bringing many participants into the normal range Significant improvements in fasting glucose and insulin sensitivity Phase 3 Trials Eli Lilly initiated Phase 3 clinical trials for retatrutide in late 2023
If theres one step worth investing in, this is the one people swear by
